Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

Patterns of stereotactic body radiation therapy: The influence of lung cancer treatment on prostate cancer treatment.

Jacobs BL, Yabes JG, Lopa SH, Heron DE, Chang CH, Bekelman JE, Nelson JB, Bynum JPW, Barnato AE, Kahn JM.

Urol Oncol. 2019 Nov 4. pii: S1078-1439(19)30382-5. doi: 10.1016/j.urolonc.2019.09.031. [Epub ahead of print]

PMID:
31699490
2.

Prior extinction increases acquisition context specificity in human predictive learning.

Ogallar PM, Rosas JM, Ramos-Álvarez MM, Alcalá JA, Nelson JB, Aranzubia M, Callejas-Aguilera JE.

Behav Processes. 2019 Oct 13;169:103984. doi: 10.1016/j.beproc.2019.103984. [Epub ahead of print]

PMID:
31618672
3.

A novel small molecule targets androgen receptor and its splice variants in castration-resistant prostate cancer.

Yang Z, Wang D, Johnson JK, Pascal LE, Takubo K, Avula R, Chakka AB, Zhou J, Chen W, Zhong M, Song Q, Ding H, Wu Z, Chandran UR, Maskrey TS, Nelson JB, Wipf P, Wang Z.

Mol Cancer Ther. 2019 Sep 25. pii: molcanther.0489.2019. doi: 10.1158/1535-7163.MCT-19-0489. [Epub ahead of print]

PMID:
31554654
4.

Reversal training facilitates acquisition of new learning in a Morris water maze.

Alcalá JA, Callejas-Aguilera JE, Nelson JB, Rosas JM.

Learn Behav. 2019 Aug 20. doi: 10.3758/s13420-019-00392-7. [Epub ahead of print]

PMID:
31432402
5.

The Influence of Stereotactic Body Radiation Therapy Adoption on Prostate Cancer Treatment Patterns.

Jacobs BL, Yabes JG, Lopa SH, Heron DE, Chang CH, Bekelman JE, Nelson JB, Bynum JPW, Barnato AE, Kahn JM.

J Urol. 2019 Jul 30:101097JU0000000000000471. doi: 10.1097/JU.0000000000000471. [Epub ahead of print]

PMID:
31361571
6.

E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.

Li F, Pascal LE, Stolz DB, Wang K, Zhou Y, Chen W, Xu Y, Chen Y, Dhir R, Parwani AV, Nelson JB, DeFranco DB, Yoshimura N, Balasubramani GK, Gingrich JR, Maranchie JK, Jacobs BL, Davies BJ, Hrebinko RL, Bigley JD, McBride D, Guo P, He D, Wang Z.

Prostate. 2019 Aug;79(11):1226-1237. doi: 10.1002/pros.23806. Epub 2019 Jun 18.

PMID:
31212363
7.

Change in Functional Status After Prostate Cancer Treatment Among Medicare Advantage Beneficiaries.

Jacobs BL, Lopa SH, Yabes JG, Nelson JB, Barnato AE, Degenholtz HB.

Urology. 2019 Sep;131:104-111. doi: 10.1016/j.urology.2019.05.029. Epub 2019 Jun 7.

PMID:
31181274
8.

Conditioned anticipatory outcome searching in humans.

Nelson JB, Navarro A, Sanjuan MDC.

Behav Processes. 2019 Jul;164:237-251. doi: 10.1016/j.beproc.2019.05.015. Epub 2019 May 14.

PMID:
31100330
9.

Perceptual learning after test-stimulus exposure in humans.

Sanjuan MDC, Nelson JB.

Behav Processes. 2019 May;162:1-6. doi: 10.1016/j.beproc.2019.01.005. Epub 2019 Jan 23.

PMID:
30684733
10.

Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells.

Dong J, Wu Z, Wang D, Pascal LE, Nelson JB, Wipf P, Wang Z.

Mol Cancer Ther. 2019 Jan;18(1):39-50. doi: 10.1158/1535-7163.MCT-18-0432. Epub 2018 Oct 8.

PMID:
30297360
11.

Learning to learn in conditioning and extinction in humans.

Balea P, Sanjuan MDC, Nelson JB.

Behav Processes. 2018 Dec;157:148-160. doi: 10.1016/j.beproc.2018.09.005. Epub 2018 Sep 24.

PMID:
30261206
12.

Effect of multimodal analgesia with paravertebral blocks on biochemical recurrence in men undergoing open radical prostatectomy.

Macleod LC, Turner RM 2nd, Lopa S, Hugar LA, Davies BJ, Ben-David B, Chelly JE, Jacobs BL, Nelson JB.

Urol Oncol. 2018 Aug;36(8):364.e9-364.e14. doi: 10.1016/j.urolonc.2018.05.016. Epub 2018 Jun 7.

PMID:
29887239
13.

Episodic β-cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice.

Tersey SA, Levasseur EM, Syed F, Farb TB, Orr KS, Nelson JB, Shaw JL, Bokvist K, Mather KJ, Mirmira RG.

FASEB J. 2018 May 29:fj201800150RR. doi: 10.1096/fj.201800150RR. [Epub ahead of print]

14.

Hypoglycemia in a Patient With a Polyhormonal Pancreatic Neuroendocrine Tumor With Evidence of Endocrine Progenitors.

Simons ZB, Morgan RC, Rose L, Nelson JB, Tersey SA, Mirmira RG.

J Endocr Soc. 2018 Jan 16;2(2):172-177. doi: 10.1210/js.2017-00409. eCollection 2018 Feb 1.

15.

The effects of extinction-aroused attention on context conditioning.

Nelson JB, Fabiano AM, Lamoureux JA.

Learn Mem. 2018 Mar 15;25(4):165-175. doi: 10.1101/lm.046201.117. Print 2018 Apr.

16.

BCL-2 and BCL-XL expression are down-regulated in benign prostate hyperplasia nodules and not affected by finasteride and/or celecoxib.

Li F, Pascal LE, Zhou J, Zhou Y, Wang K, Parwani AV, Dhir R, Guo P, He D, Nelson JB, Wang Z.

Am J Clin Exp Urol. 2018 Feb 5;6(1):1-10. eCollection 2018.

17.

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.

Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR.

J Urol. 2018 Apr;199(4):990-997. doi: 10.1016/j.juro.2018.01.002. Epub 2018 Jan 10.

PMID:
29331546
18.

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.

Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR.

J Urol. 2018 Mar;199(3):683-690. doi: 10.1016/j.juro.2017.11.095. Epub 2017 Dec 15. Review.

PMID:
29203269
19.

ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells.

Zang Y, Pascal LE, Zhou Y, Qiu X, Wei L, Ai J, Nelson JB, Zhong M, Xue B, Wang S, Yang D, Lan L, Shan Y, Wang Z.

Cancer Lett. 2018 Feb 28;415:198-207. doi: 10.1016/j.canlet.2017.11.028. Epub 2017 Nov 26.

20.

Recovery of attention with renewal.

Nelson JB, Craddock P, Molet M, Renaux C.

Learn Mem. 2017 Nov 15;24(12):637-640. doi: 10.1101/lm.045682.117. Print 2017 Dec.

21.

Editorial Comment.

Nelson JB.

J Urol. 2018 Jan;199(1):256. doi: 10.1016/j.juro.2017.07.109. Epub 2017 Oct 13. No abstract available.

PMID:
29031670
22.

Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.

Wang Y, Pascal LE, Zhong M, Ai J, Wang D, Jing Y, Pilch J, Song Q, Rigatti LH, Graham LE, Nelson JB, Parwani AV, Wang Z.

Endocrinology. 2017 Dec 1;158(12):4189-4205. doi: 10.1210/en.2017-00409.

23.

DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor.

Jing Y, Nguyen MM, Wang D, Pascal LE, Guo W, Xu Y, Ai J, Deng FM, Masoodi KZ, Yu X, Zhang J, Nelson JB, Xia S, Wang Z.

Oncogene. 2018 Feb 1;37(5):638-650. doi: 10.1038/onc.2017.371. Epub 2017 Oct 9.

24.

Inhibition of Androgen Receptor Function and Level in Castration-Resistant Prostate Cancer Cells by 2-[(isoxazol-4-ylmethyl)thio]-1-(4-phenylpiperazin-1-yl)ethanone.

Masoodi KZ, Eisermann K, Yang Z, Dar JA, Pascal LE, Nguyen M, O'Malley K, Parrinello E, Feturi FG, Kenefake AN, Nelson JB, Johnston PA, Wipf P, Wang Z.

Endocrinology. 2017 Oct 1;158(10):3152-3161. doi: 10.1210/en.2017-00408.

25.

The Ongoing Challenge of Urinary Incontinence after Radical Prostatectomy.

Nelson JB.

J Urol. 2017 Dec;198(6):1223-1225. doi: 10.1016/j.juro.2017.09.053. Epub 2017 Sep 14. No abstract available.

PMID:
28919315
26.

A system for detecting high impact-low frequency mutations in primary tumors and metastases.

Anjanappa M, Hao Y, Simpson ER, Bhat-Nakshatri P, Nelson JB, Tersey SA, Mirmira RG, Cohen-Gadol AA, Saadatzadeh MR, Li L, Fang F, Nephew KP, Miller KD, Liu Y, Nakshatri H.

Oncogene. 2018 Jan 11;37(2):185-196. doi: 10.1038/onc.2017.322. Epub 2017 Sep 11.

27.

Mindful Eating: The Art of Presence While You Eat.

Nelson JB.

Diabetes Spectr. 2017 Aug;30(3):171-174. doi: 10.2337/ds17-0015.

28.

Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes.

Hernandez-Perez M, Chopra G, Fine J, Conteh AM, Anderson RM, Linnemann AK, Benjamin C, Nelson JB, Benninger KS, Nadler JL, Maloney DJ, Tersey SA, Mirmira RG.

Diabetes. 2017 Nov;66(11):2875-2887. doi: 10.2337/db17-0215. Epub 2017 Aug 25.

29.

Corrigendum to "Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion" [Neoplasia 19 (2017) 207-215].

Qiu X, Pascal LE, Song Q, Zang Y, Ai J, O'Malley KJ, Nelson JB, Wang Z.

Neoplasia. 2017 Aug;19(8):659. doi: 10.1016/j.neo.2017.05.005. No abstract available.

30.

Inhibition of Androgen Receptor Nuclear Localization and Castration-Resistant Prostate Tumor Growth by Pyrroloimidazole-based Small Molecules.

Masoodi KZ, Xu Y, Dar JA, Eisermann K, Pascal LE, Parrinello E, Ai J, Johnston PA, Nelson JB, Wipf P, Wang Z.

Mol Cancer Ther. 2017 Oct;16(10):2120-2129. doi: 10.1158/1535-7163.MCT-17-0176. Epub 2017 Jun 27.

31.

Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene.

Chen ZH, Yu YP, Zuo ZH, Nelson JB, Michalopoulos GK, Monga S, Liu S, Tseng G, Luo JH.

Nat Biotechnol. 2017 Jun;35(6):543-550. doi: 10.1038/nbt.3843. Epub 2017 May 1.

32.

The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.

Jacobs BL, Yabes JG, Lopa SH, Heron DE, Chang CH, Schroeck FR, Bekelman JE, Kahn JM, Nelson JB, Barnato AE.

Cancer. 2017 Aug 1;123(15):2945-2954. doi: 10.1002/cncr.30574. Epub 2017 Mar 16.

33.

MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.

Chen ZH, Yu YP, Tao J, Liu S, Tseng G, Nalesnik M, Hamilton R, Bhargava R, Nelson JB, Pennathur A, Monga SP, Luketich JD, Michalopoulos GK, Luo JH.

Gastroenterology. 2017 Oct;153(4):1120-1132.e15. doi: 10.1053/j.gastro.2016.12.036. Epub 2017 Feb 27.

34.

Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion.

Qiu X, Pascal LE, Song Q, Zang Y, Ai J, O'Malley KJ, Nelson JB, Wang Z.

Neoplasia. 2017 Mar;19(3):207-215. doi: 10.1016/j.neo.2017.01.001. Epub 2017 Feb 3. Erratum in: Neoplasia. 2017 Aug;19(8):659.

35.

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death.

Tersey SA, Nelson JB, Fisher MM, Mirmira RG.

J Vis Exp. 2016 Dec 21;(118). doi: 10.3791/54838.

36.

Prognostic implications of immediate PSA response to early salvage radiotherapy.

Turner I I RM, Yabes JG, Woldemichael E, Deutsch MM, Smith RP, Werner RS, Jacobs BL, Nelson JB.

Can J Urol. 2016 Dec;23(6):8568-8575.

PMID:
27995853
37.

The effect of limited (tertiary) Gleason pattern 5 on the new prostate cancer grade groups.

Baras AS, Nelson JB, Han M, Parwani AV, Epstein JI.

Hum Pathol. 2017 May;63:27-32. doi: 10.1016/j.humpath.2016.12.008. Epub 2016 Dec 16.

PMID:
27993581
38.

Biopsy Perineural Invasion in Prostate Cancer Patients Who Are Candidates for Active Surveillance by Strict and Expanded Criteria.

Turner RM 2nd, Yecies TS, Yabes JG, Ristau BT, Woldemichael E, Davies BJ, Jacobs BL, Nelson JB.

Urology. 2017 Apr;102:173-177. doi: 10.1016/j.urology.2016.11.011. Epub 2016 Nov 15.

39.

MRI should be routine for all patients with localized prostate cancer? | Opinion: No.

Nelson JB.

Int Braz J Urol. 2016 Nov-Dec;42(6):1065-1068. doi: 10.1590/S1677-5538.IBJU.2016.06.04. No abstract available.

40.

EAF2 regulates DNA repair through Ku70/Ku80 in the prostate.

Ai J, Pascal LE, Wei L, Zang Y, Zhou Y, Yu X, Gong Y, Nakajima S, Nelson JB, Levine AS, Lan L, Wang Z.

Oncogene. 2017 Apr;36(15):2054-2065. doi: 10.1038/onc.2016.373. Epub 2016 Oct 10.

41.

Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic Mice.

Maganti AV, Tersey SA, Syed F, Nelson JB, Colvin SC, Maier B, Mirmira RG.

J Biol Chem. 2016 Oct 21;291(43):22524-22533. Epub 2016 Sep 9.

42.

Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer.

Johnson JK, Skoda EM, Zhou J, Parrinello E, Wang D, O'Malley K, Eyer BR, Kazancioglu M, Eisermann K, Johnston PA, Nelson JB, Wang Z, Wipf P.

ACS Med Chem Lett. 2016 May 27;7(8):785-90. doi: 10.1021/acsmedchemlett.6b00186. eCollection 2016 Aug 11.

43.

Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading.

Lyon TD, Turner RM 2nd, Yabes JG, Woldemichael E, Davies BJ, Jacobs BL, Nelson JB.

Urology. 2016 Nov;97:153-159. doi: 10.1016/j.urology.2016.08.004. Epub 2016 Aug 8.

PMID:
27516122
44.

Local coverage determination policy and the use of stereotactic body radiation therapy for prostate cancer.

Jacobs BL, Sunderland R, Yabes J, Nelson JB, Barnato AE, Bekelman JE.

Urol Pract. 2015 Nov;2(6):304-311.

45.

Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population.

Jacobs BL, Lopa SH, Yabes JG, Nelson JB, Barnato AE, Degenholtz HB.

Cancer. 2016 Oct 15;122(20):3199-3206. doi: 10.1002/cncr.30184. Epub 2016 Jul 5.

46.

Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells.

Johnston PA, Nguyen MM, Dar JA, Ai J, Wang Y, Masoodi KZ, Shun T, Shinde S, Camarco DP, Hua Y, Huryn DM, Wilson GM, Lazo JS, Nelson JB, Wipf P, Wang Z.

Assay Drug Dev Technol. 2016 May;14(4):226-39. doi: 10.1089/adt.2016.716.

47.

Ambiguity produces attention shifts in category learning.

Vadillo MA, Orgaz C, Luque D, Nelson JB.

Learn Mem. 2016 Mar 15;23(4):134-40. doi: 10.1101/lm.041145.115. Print 2016 Apr.

48.

Editorial Comment.

Nelson JB.

J Urol. 2016 May;195(5):1414. doi: 10.1016/j.juro.2015.11.088. Epub 2016 Feb 4. No abstract available.

PMID:
26851999
49.

Patients Present with More Advanced Prostate Cancer since the USPSTF Screening Recommendations.

Barry MJ, Nelson JB.

J Urol. 2015 Dec;194(6):1534-6. doi: 10.1016/j.juro.2015.09.033. Epub 2015 Sep 15. No abstract available.

PMID:
26384450
50.

Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes.

Yu YP, Liu S, Huo Z, Martin A, Nelson JB, Tseng GC, Luo JH.

PLoS One. 2015 Aug 21;10(8):e0135982. doi: 10.1371/journal.pone.0135982. eCollection 2015.

Supplemental Content

Loading ...
Support Center